share_log

Atea Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(4.8%),TANG CAPITAL MANAGEMENT, LLC(4.8%), etc.

Atea Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(4.8%),TANG CAPITAL MANAGEMENT, LLC(4.8%)等

SEC announcement ·  2023/11/28 06:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息